Programming CRISPR to fight viruses could lead to new treatments for Ebola, Zika

crispr could make you immune to the flu x
Image: Niaid/Tag Hartman-Simkins

CRISPR is usually thought of as a laboratory tool to edit DNA in order to fix genetic defects or enhance certain traits—but the mechanism originally evolved in bacteria as a way to fend off viruses called bacteriophages. Now, scientists have found a way to adapt this ability to fight viruses in human cells.

In a recent study, Catherine Freije and Cameron Myhrvold of the Broad Institute of MIT and Harvard and their colleagues programmed a CRISPR-related enzyme to target three different single-stranded RNA viruses in human embryonic kidney cells (as well as human lung cancer cells and dog kidney cells) grown in vitro, and chop them up, rendering them largely unable to infect additional cells. If further experiments show this process works in living animals, it could eventually lead to new antiviral therapies for diseases such as Ebola or Zika in humans.

Related article:  Why do many COVID patients lose their sense of smell? Here are some answers

Beyond therapeutics, the team hopes to understand more about how viruses operate—how they replicate and what parts of their genomes are most important. Using approaches like this, “you can really start to get a better picture of what parts of these viruses are, and most importantly, what really makes them tick.”

ADVERTISEMENT

Read full, original post: Scientists Program CRISPR to Fight Viruses in Human Cells

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend